The body has a veritable army constantly on guard to keep us safe from microscopic threats from infections to cancer.
Sutro inks $390M royalty financing deal with Blackstone; Clinical hold on Pharvaris’ HAE drug lifted
Sutro Biopharma is landing a $140 million upfront in exchange for handing off its royalty in potential future sales of Vaxcyte’s candidates. The deal, announced